Bitter melon extract attenuating hepatic steatosis may be mediated by FGF21 and AMPK/Sirt1 signaling in mice
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Bitter melon extract attenuating hepatic steatosis may be mediated by FGF21 and AMPK/Sirt1 signaling in mice
Authors
Keywords
-
Journal
Scientific Reports
Volume 3, Issue 1, Pages -
Publisher
Springer Nature
Online
2013-11-05
DOI
10.1038/srep03142
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Momordica charantia and Its Novel Polypeptide Regulate Glucose Homeostasis in Mice via Binding to Insulin Receptor
- (2013) Hsin-Yi Lo et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- Differential Specificity of Endocrine FGF19 and FGF21 to FGFR1 and FGFR4 in Complex with KLB
- (2012) Chaofeng Yang et al. PLoS One
- High Plasma Level of Fibroblast Growth Factor 21 Is an Independent Predictor of Type 2 Diabetes: A 5.4-year population-based prospective study in Chinese subjects
- (2011) C. Chen et al. DIABETES CARE
- Fibroblast Growth Factor 21 Induces Glucose Transporter-1 Expression through Activation of the Serum Response Factor/Ets-Like Protein-1 in Adipocytes
- (2011) Xuan Ge et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Dynamic recruitment of licensing factor Cdt1 to sites of DNA damage
- (2011) V. Roukos et al. JOURNAL OF CELL SCIENCE
- Momordica charantia Seed Extract Reduces Pre-Adipocyte Viability, Affects Lactate Dehydrogenase Release, and Lipid Accumulation in 3T3-L1 Cells
- (2011) David G. Popovich et al. JOURNAL OF MEDICINAL FOOD
- Momordica charantia (bitter melon) attenuates high-fat diet-associated oxidative stress and neuroinflammation
- (2011) Pratibha V Nerurkar et al. Journal of Neuroinflammation
- Supplementation of Bitter Melon to Rats Fed a High-Fructose Diet During Gestation and Lactation Ameliorates Fructose-Induced Dyslipidemia and Hepatic Oxidative Stress in Male Offspring
- (2011) Rachel H. H. Ching et al. JOURNAL OF NUTRITION
- Bioactives from bitter melon enhance insulin signaling and modulate acyl carnitine content in skeletal muscle in high-fat diet-fed mice
- (2011) Zhong Q. Wang et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Strategies to improve palatability and increase consumption intentions for Momordica charantia(bitter melon): A vegetable commonly used for diabetes management
- (2011) Laura S Snee et al. Nutrition Journal
- Physiological modulation of circulating FGF21: relevance of free fatty acids and insulin
- (2010) Knut Mai et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Fibroblast Growth Factor 21 Action in the Brain Increases Energy Expenditure and Insulin Sensitivity in Obese Rats
- (2010) D. A. Sarruf et al. DIABETES
- Obesity Is a Fibroblast Growth Factor 21 (FGF21)-Resistant State
- (2010) f. M. Fisher et al. DIABETES
- Increased Fibroblast Growth Factor 21 in Obesity and Nonalcoholic Fatty Liver Disease
- (2010) Jody Dushay et al. GASTROENTEROLOGY
- Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: The central role of nontriglyceride fatty acid metabolites
- (2010) Brent A. Neuschwander-Tetri HEPATOLOGY
- Fibroblast growth factor 21 as a biomarker for NAFLD: Integrating pathobiology into clinical practice
- (2010) Gareth Morris-Stiff et al. JOURNAL OF HEPATOLOGY
- Fibroblast growth factor 21 levels are increased in nonalcoholic fatty liver disease patients and are correlated with hepatic triglyceride
- (2010) Huating Li et al. JOURNAL OF HEPATOLOGY
- Fibroblast growth factor 21 regulates energy metabolism by activating the AMPK–SIRT1–PGC-1α pathway
- (2010) Mary D. L. Chau et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- FGF21 reloaded: challenges of a rapidly growing field
- (2010) Alexei Kharitonenkov et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Fibroblast growth factor 21: from pharmacology to physiology
- (2009) Steven A Kliewer et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Anti-diabetic and hypoglycaemic effects of Momordica charantia (bitter melon): a mini review
- (2009) Lawrence Leung et al. BRITISH JOURNAL OF NUTRITION
- Free Fatty Acids Link Metabolism and Regulation of the Insulin-Sensitizing Fibroblast Growth Factor-21
- (2009) K. Mai et al. DIABETES
- Fibroblast Growth Factor-21 Is Induced in Human Skeletal Muscles by Hyperinsulinemia
- (2009) Pernille Hojman et al. DIABETES
- Circulating Fibroblast Growth Factor-21 Is Elevated in Impaired Glucose Tolerance and Type 2 Diabetes and Correlates With Muscle and Hepatic Insulin Resistance
- (2009) A. O. Chavez et al. DIABETES CARE
- Serum Fibroblast Growth Factor 21 Is Associated with Adverse Lipid Profiles and γ-Glutamyltransferase But Not Insulin Sensitivity in Chinese Subjects
- (2009) Huating Li et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Momordica charantia (bitter melon) reduces plasma apolipoprotein B-100 and increases hepatic insulin receptor substrate and phosphoinositide-3 kinase interactions
- (2008) Pratibha V. Nerurkar et al. BRITISH JOURNAL OF NUTRITION
- Antidiabetic Activities of Triterpenoids Isolated from Bitter Melon Associated with Activation of the AMPK Pathway
- (2008) Min-Jia Tan et al. CHEMISTRY & BIOLOGY
- Serum concentrations and tissue expression of a novel endocrine regulator fibroblast growth factor-21 in patients with type 2 diabetes and obesity
- (2008) M. Mraz et al. CLINICAL ENDOCRINOLOGY
- How Insulin Receptor Substrate Proteins Regulate the Metabolic Capacity of the Liver - Implications for Health and Disease
- (2008) Louise Fritsche et al. CURRENT MEDICINAL CHEMISTRY
- Fibroblast Growth Factor 21 Reverses Hepatic Steatosis, Increases Energy Expenditure, and Improves Insulin Sensitivity in Diet-Induced Obese Mice
- (2008) J. Xu et al. DIABETES
- Obesity and the Metabolic Syndrome in Developing Countries
- (2008) Anoop Misra et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- FGF-21/FGF-21 receptor interaction and activation is determined by βKlotho
- (2007) Alexei Kharitonenkov et al. JOURNAL OF CELLULAR PHYSIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started